Public Health
-
Health & Medicine
Heidi Overton Faces Senate Scrutiny as Trump’s FDA Commissioner Nominee Amidst Ideological Pressures
The confirmation hearing for Dr. Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, unfolded in Washington…
Read More » -
Health & Medicine
FDA Issues Final Rule Modernizing Nonclinical Testing Terminology to Favor Human-Centric Research Methods
In a significant regulatory shift aimed at accelerating the adoption of human-based biomedical research, the Department of Health and Human…
Read More » -
Health & Medicine
When the Safety Net Frays: Rising Premiums and Policy Shifts Force Healthcare Workers to Go Without Insurance
BOISE, Idaho — For Joshua and Ashley Durham, operating a private family medicine practice has meant navigating the intricate bureaucratic…
Read More » -
Health & Medicine
FDA Finalizes Regulatory Shift Toward Human-Centric Research Methods to Reduce Reliance on Animal Models
In a definitive pivot toward modernizing the American biomedical research landscape, the Department of Health and Human Services (HHS) and…
Read More » -
Health & Medicine
When Insurance Fails the Healers: Inside the Rising Crisis of Uninsured Healthcare Workers Across America
BOISE, Idaho — For Joshua and Ashley Durham, managing a family medicine practice in Idaho has always meant navigating the…
Read More » -
Health & Medicine
Beyond the Clinic Walls: Why Public Health Experts Are Rethinking Suicide Prevention in America
The 988 Suicide & Crisis Lifeline serves as an immediate, critical intervention point for individuals experiencing acute mental health distress…
Read More » -
Health & Medicine
White House Push to Centralize NIH Grant Approval Sparks Congressional Firestorm and Scientific Policy Crisis
The fundamental autonomy of the National Institutes of Health (NIH) is facing an unprecedented challenge as the executive branch moves…
Read More » -
Health & Medicine
Radiopharma players merge after a surprise FDA rejection, Novo plans to expand its pipeline, and more biotech news
The landscape of the biotechnology sector shifted significantly on September 21, 2026, as a series of strategic maneuvers—ranging from forced…
Read More » -
Health & Medicine
Grail Shares Surge as FDA Documents Signal Potential Path Toward Approval for Multi-Cancer Early Detection Test
Shares of Grail, the pioneer in multi-cancer early detection (MCED) technology, experienced a significant market rally on Monday, climbing 33%…
Read More » -
Health & Medicine
Rising Healthcare Costs Take Center Stage as a Decisive Issue in Upcoming Midterm Elections
As the United States inches closer to the high-stakes midterm elections, an escalating financial anxiety is gripping households nationwide: the…
Read More »
